RPE based gene and cell therapy for inherited retinal diseases: A review
- 29 January 2022
- journal article
- review article
- Published by Elsevier in Experimental Eye Research
- Vol. 217, 108961
Abstract
No abstract availableKeywords
Funding Information
- Shiraz University of Medical Sciences (22322)
This publication has 82 references indexed in Scilit:
- POD Nanoparticles Expressing GDNF Provide Structural and Functional Rescue of Light-induced Retinal Degeneration in an Adult MouseMolecular Therapy, 2010
- Bestrophins and retinopathiesPflügers Archiv - European Journal of Physiology, 2010
- Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 YearHuman Gene Therapy, 2009
- RETRACTED ARTICLE: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsGene Therapy, 2009
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyGene Therapy, 2008
- Leber Congenital Amaurosis–A Model for Efficient Genetic Testing of Heterogeneous Disorders: LXIV Edward Jackson Memorial LectureAmerican Journal of Ophthalmology, 2007
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006